DUBLIN–(BUSINESS WIRE)–The “Social Anxiety Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players” report has been added to ResearchAndMarkets.com’s offering. Social Anxiety Disorder (SAD/Social Phobia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Social Anxiety Disorder (SAD/Social Phobia) pipeline landscape. … [Read more…]

uPerform achieves APN Advanced Tier Member designation for its expertise with AWS ELKRIDGE, Md.–(BUSINESS WIRE)–#uPerform—uPerform the market-leading just-in-time training and support platform, announces that it successfully achieved Amazon Web Services Partner Network (APN) Advanced Tier Member status. Amazon Web Services (AWS) recognizes its APN Advanced Tier members due to their knowledge, experience, and customer success … [Read more…]

RALEIGH, N.C.–(BUSINESS WIRE)–MobileSmith (OTCBB: MOST), a leading provider of cutting-edge mobile software solutions, announces the appointment of Christine Havlin as their Chief Marketing Officer. “As MSH adds more clinical functionality to our platform it became a strategic imperative to add a marketing leader with deep provider experience. We are thrilled to add Christine to lead … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Healthcare Asset Management Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The global healthcare asset management market reached a value of US$ 13.35 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 25.93 Billion by 2027, exhibiting at a … [Read more…]

The new service line seeks to connect fertility to comprehensive women’s healthcare with unbiased counseling, prevention-focused care, and mental health support The women’s healthcare start-up also released its first brand campaign called “Trying” questioning the social pressure put on women in their fertility journeys & choices NEW YORK–(BUSINESS WIRE)–Tia, the modern medical home for women, … [Read more…]

– ANNOVERA is the only FDA-approved procedure-free, long-lasting, reversible birth control – – With this approval, the Company expects a significant reduction in its manufacturing batch rejections and an increase in future product supply and will enable the Company to better meet short- and long-term customer demand – BOCA RATON, Fla.–(BUSINESS WIRE)–TherapeuticsMD, Inc. (NASDAQ:TXMD) (“TXMD” … [Read more…]

CHICAGO–(BUSINESS WIRE)–Shore Capital Partners (“Shore” or “Shore Capital”) is pleased to announce it has completed a partnership with AA Medical, a provider of sustainable solutions to both the new and resale medical device equipment markets based in Mokena, Illinois, with a second location in Miami, Florida. AA Medical was founded in 2012 by Ron Plantz … [Read more…]

SAN DIEGO & VANCOUVER, British Columbia–(BUSINESS WIRE)–Tentarix Biotherapeutics LP, a biotechnology company developing first-in-class targeted, conditional antibody-based multifunctional biotherapies, today announced the formation of a Scientific Advisory Board (SAB) and appointments to its Board of Directors and leadership team. The SAB, initially comprised of three experts in immunology, cancer biology and protein engineering, will provide … [Read more…]

Heart Failure 2022 Presentation Includes Preclinical Data Supporting TN-301 Effect in HFpEF Models TN-301 IND Submission on Track for Second Half of 2022 SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, announced that … [Read more…]

Opinion granted based on positive results from the Phase 3 KEYNOTE-716 trial If approved, KEYTRUDA would be the first anti-PD-1 immunotherapy treatment option for patients 12 years and older in the EU across stage IIB, IIC and III melanoma following complete resection RAHWAY, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside the United States … [Read more…]